NL6505361A - - Google Patents

Info

Publication number
NL6505361A
NL6505361A NL6505361A NL6505361A NL6505361A NL 6505361 A NL6505361 A NL 6505361A NL 6505361 A NL6505361 A NL 6505361A NL 6505361 A NL6505361 A NL 6505361A NL 6505361 A NL6505361 A NL 6505361A
Authority
NL
Netherlands
Prior art keywords
resin
cyclodextrin
cross
inclusion
nitrophenol
Prior art date
Application number
NL6505361A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6505361A publication Critical patent/NL6505361A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/72—Encapsulation
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/74—Fixation, conservation, or encapsulation of flavouring agents with a synthetic polymer matrix or excipient, e.g. vinylic, acrylic polymers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/75—Fixation, conservation, or encapsulation of flavouring agents the flavouring agents being bound to a host by chemical, electrical or like forces, e.g. use of precursors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06—Preparation of nitro compounds
    • C07C201/16—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/16—Cyclodextrin; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
NL6505361A 1964-04-29 1965-04-27 NL6505361A (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH561564A CH445129A (fr) 1964-04-29 1964-04-29 Procédé pour la préparation de composés d'inclusion à poids moléculaire élevé

Publications (1)

Publication Number Publication Date
NL6505361A true NL6505361A (no) 1965-11-01

Family

ID=4296563

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6505361A NL6505361A (no) 1964-04-29 1965-04-27

Country Status (10)

Country Link
US (1) US3420788A (no)
BE (1) BE662174A (no)
CH (1) CH445129A (no)
DK (1) DK132259C (no)
ES (1) ES312034A1 (no)
GB (1) GB1091637A (no)
IT (1) IT961352B (no)
NL (1) NL6505361A (no)
NO (2) NO126377B (no)
SE (2) SE333240B (no)

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU177419B (en) * 1978-07-13 1981-10-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing threedimensional,retentive polymers consisting of cyclodextrin and polyvinylalcohol units,capable of forming inclusion complexes in the form of bead,fibre or mainly block
EP0013688B1 (en) * 1978-12-15 1984-02-01 Kyoshin Co., Ltd. A perfumed synthetic resin product and a method of producing said product
JPS609524B2 (ja) * 1979-06-01 1985-03-11 理化学研究所 シクロデキストリンの回収法
HU184066B (en) * 1979-12-28 1984-06-28 Chinoin Gyogyszer Es Vegyeszet Plant growth regulating substance and process for preparing such compound
HU181733B (en) * 1980-08-07 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing sorbents containing cyclodextrin on cellulose base
JPS57130914A (en) * 1981-02-04 1982-08-13 Agency Of Ind Science & Technol Prolongation of activity retention
HU189534B (en) * 1981-09-09 1986-07-28 Chinoin Rt.,Hu Process for producing new tablets containing cyclodextrin polymer as desintegrator
US4448789A (en) * 1982-08-27 1984-05-15 Warner-Lambert Company Enhanced flavor-releasing agent
HU191101B (en) * 1983-02-14 1987-01-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups
JPS6081166A (ja) * 1983-10-11 1985-05-09 Fujisawa Pharmaceut Co Ltd ２−ニトロオキシメチル−６−クロロピリジンのβ−シクロデキストリン包接化合物およびその製造法
JPS60202115A (ja) * 1984-03-27 1985-10-12 Ichiro Shibauchi エポキシ樹脂用硬化剤
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
JPS61152765A (ja) * 1984-12-27 1986-07-11 Nippon Ekishiyou Kk シクロデキストリン類で包接された化合物を含有した合成樹脂製品及びその製造方法
US4769474A (en) * 1985-04-10 1988-09-06 Mitsui Toatsu Chemicals, Inc. Process for purifying tryptophane
SE452469B (sv) * 1986-06-18 1987-11-30 Pharmacia Ab Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
US4897472A (en) * 1986-11-19 1990-01-30 Oy Alko Ab Process for isolation and purification of cyclodextrins
US5273820A (en) * 1986-12-08 1993-12-28 American Maize-Products Company Separation and purification of cyclodextrins
US4808232A (en) * 1986-12-08 1989-02-28 American Maize-Products Company Separation and purification of cyclodextrins
US4898921A (en) * 1987-06-03 1990-02-06 Montclair State College Conducting polymer films, method of manufacture and applications therefor
US5760015A (en) * 1988-01-19 1998-06-02 The Trustees Of The University Of Pennsylvania Cyclodextrin compounds and methods of making and use thereof
US5637575A (en) * 1988-01-19 1997-06-10 The Trustees Of The University Of Pennsylvania Methods of inhibiting restenosis
US5658894A (en) * 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
JPH0269540A (ja) * 1988-09-05 1990-03-08 Chisso Corp 結晶性ポリオレフイン組成物
US5441944A (en) * 1989-04-23 1995-08-15 The Trustees Of The University Of Pennsylvania Substituted cyclodextrin sulfates and their uses as growth modulating agents
US5075432A (en) * 1989-08-11 1991-12-24 Edward Vanzo Spherical cyclodextrin polymer beads
IT1255981B (it) * 1991-04-30 1995-11-17 Ministero Dell Uni E Della Composizione adesiva a piu' componenti
US5446030A (en) * 1991-09-19 1995-08-29 Weisz; Paul B. Prevention of hemolysis
CA2159717A1 (en) * 1993-03-31 1994-10-13 Elliot Barnathan Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor
US5492947A (en) * 1994-06-23 1996-02-20 Aspen Research Corporation Barrier material comprising a thermoplastic and a compatible cyclodextrin derivative
US6048736A (en) * 1998-04-29 2000-04-11 Kosak; Kenneth M. Cyclodextrin polymers for carrying and releasing drugs
AU2003294258B2 (en) * 2003-01-16 2009-05-28 Cornell Research Foundation, Inc. Partially biodegradable temperature and pH sensitive hydrogel
AU2004263830B2 (en) 2003-06-13 2008-12-18 Alnylam Pharmaceuticals, Inc. Double-stranded ribonucleic acid with increased effectiveness in an organism
CA2548917C (en) 2003-12-11 2014-09-23 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
JP5070038B2 (ja) 2004-02-24 2012-11-07 ザ ジェネラル ホスピタル コーポレーション 触媒性放射性フッ素化
EP3034510A1 (en) 2004-04-30 2016-06-22 Alnylam Pharmaceuticals Inc. Oligonucleotides comprising a c5-modified pyrimidine
RU2416606C2 (ru) 2004-06-17 2011-04-20 Инфинити Дискавери, Инк. Соединения и способы для ингибирования взаимодействия bcl белков с компонентами по связыванию
EP1848437A4 (en) * 2005-02-18 2012-04-25 Surface Logix Inc METHOD FOR PRODUCING PHARMACOKINETIC IMPROVED COMPOUNDS WITH FUNCTIONAL RESTORATIONS OR GROUPS AND PHARMACEUTICAL COMPOSITIONS WITH THESE COMPOUNDS
JP2008530247A (ja) * 2005-02-18 2008-08-07 サーフェイス ロジックス，インコーポレイティド 薬物動態学的に改善された化合物
ES2310948B2 (es) * 2005-02-25 2009-09-16 Universidade De Santiago De Compostela Procedimiento de obtencion de hidrogeles de ciclodextrinas con glicidileteres, las composiciones obtenidas y sus aplicaciones.
US8669236B2 (en) * 2005-05-12 2014-03-11 The General Hospital Corporation Biotinylated compositions
KR100791978B1 (ko) * 2005-06-21 2008-01-04 곽해수 콜레스테롤 제거용 베타-싸이클로덱스트린의 가교화 및그의 재생방법
JP5270545B2 (ja) 2006-08-03 2013-08-21 タフツ ユニバーシティー／トラスティーズ オブ タフツ カレッジ フラッシングのないナイアシン類似体およびそれらの使用法
KR100785913B1 (ko) * 2006-11-29 2007-12-17 한국과학기술연구원 경화된 β-사이클로덱스트린 중합체 분말과 그의 제조방법
WO2009013770A1 (en) * 2007-07-26 2009-01-29 Humanitas Mirasole S.P.A. Derivatised polysaccharide material for the transdermal administration of drugs
WO2009032199A1 (en) * 2007-08-31 2009-03-12 The Board Of Trustees Operating Beta-cyclodextrins as nucleating agents for poly(lactic acid)
US8871918B2 (en) 2008-10-24 2014-10-28 Sarepta Therapeutics, Inc. Multiple exon skipping compositions for DMD
TWI495473B (zh) 2009-11-13 2015-08-11 Sarepta Therapeutics Inc 反義抗病毒化合物及治療流感病毒感染的方法
EP2545173A2 (en) 2010-03-12 2013-01-16 Sarepta Therapeutics, Inc. Antisense modulation of nuclear hormone receptors
ES2816898T3 (es) 2010-05-13 2021-04-06 Sarepta Therapeutics Inc Compuestos que modulan la actividad de señalización de las interleucinas 17 y 23
AU2011270726C1 (en) 2010-06-24 2016-02-18 Arisaph Pharmaceuticals, Inc. Niacin mimetics, and methods of use thereof
JP5925770B2 (ja) 2010-06-24 2016-05-25 トラスティーズ オブ タフツ カレッジ ナイアシン模倣体、およびその使用方法
US10463687B2 (en) 2011-01-20 2019-11-05 Cornell University Treatments for retinal disorders
CA2839593A1 (en) 2011-07-15 2013-01-24 Sarepta Therapeutics, Inc. Methods and compositions for manipulating translation of protein isoforms from alternative initiation start sites
ES2935606T3 (es) 2011-12-08 2023-03-08 Sarepta Therapeutics Inc Análogos de oligonucleótidos dirigidos a LMNA humana
BR112014015322A2 (pt) 2011-12-23 2017-06-13 Novartis Ag compostos e composições para inibir a interação de bcl2 com parceiros de ligação
BR112014015339A2 (pt) 2011-12-23 2017-06-13 Novartis Ag compostos para inibição da interação de bcl2 com parceiros de ligação
JP2015503517A (ja) 2011-12-23 2015-02-02 ノバルティス アーゲー Ｂｃｌ２と結合相手の相互作用を阻害するための化合物
MX2014007729A (es) 2011-12-23 2015-01-12 Novartis Ag Compuestos para inhibir la interaccion de bcl2 con los componentes de enlace.
JP2015503516A (ja) 2011-12-23 2015-02-02 ノバルティス アーゲー Ｂｃｌ２と結合相手の相互作用を阻害するための化合物
CN104334529B (zh) 2012-05-15 2017-03-15 诺华股份有限公司 用于抑制abl1、abl2和bcr‑abl1的活性的化合物和组合物
CA2871715A1 (en) 2012-05-15 2013-11-21 Novartis Ag Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
JP6078640B2 (ja) 2012-05-15 2017-02-08 ノバルティス アーゲー Ａｂｌ１、ａｂｌ２およびｂｃｒ−ａｂｌ１の活性を阻害するためのベンズアミド誘導体
NZ701626A (en) 2012-05-15 2016-02-26 Novartis Ag Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
EP3441467A3 (en) 2012-08-31 2019-04-24 The General Hospital Corporation Biotin complexes for treatment and diagnosis of alzheimer's disease
FR3000080B1 (fr) 2012-12-20 2015-01-30 Oreal Polycondensat de cyclodextrine insoluble dans l'eau ; utilisations comme agent de capture
CN111440796A (zh) 2012-12-20 2020-07-24 萨雷普塔医疗公司 用于治疗肌营养不良症的改良的外显子跳跃组合物
FR2999916B1 (fr) 2012-12-20 2015-01-30 Oreal Composition permettant la liberation d'agent benefique comprenant un polycondensat de cyclodextrine insoluble dans l'eau et au moins un agent benefique
AU2014219283C1 (en) 2013-02-19 2016-10-27 Novartis Ag Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
CA2906209A1 (en) 2013-03-14 2014-09-25 Sarepta Therapeutics, Inc. Exon skipping compositions for treating muscular dystrophy targeting the annealing site h44a (-07+15)
CN110066793A (zh) 2013-03-14 2019-07-30 萨勒普塔医疗公司 用于治疗肌肉萎缩的外显子跳跃组合物
JP2016516066A (ja) 2013-03-15 2016-06-02 サレプタ セラピューティクス， インコーポレイテッド 筋ジストロフィを処置するための改善された組成物
WO2015022664A1 (en) 2013-08-14 2015-02-19 Novartis Ag Compounds and compositions as inhibitors of mek
US9227969B2 (en) 2013-08-14 2016-01-05 Novartis Ag Compounds and compositions as inhibitors of MEK
WO2015022663A1 (en) 2013-08-14 2015-02-19 Novartis Ag Compounds and compositions as inhibitors of mek
WO2015092634A1 (en) 2013-12-16 2015-06-25 Novartis Ag 1,2,3,4-tetrahydroisoquinoline compounds and compositions as selective estrogen receptor antagonists and degraders
CN105899493B (zh) 2014-01-17 2019-03-29 诺华股份有限公司 用于抑制shp2活性的1-(三嗪-3-基/哒嗪-3-基)-哌(-嗪)啶衍生物及其组合物
ES2699351T3 (es) 2014-01-17 2019-02-08 Novartis Ag Derivados de 1-piridazin/triazin-3-il-piper(-azina)/idina/pirolidina y composiciones de las mismas para inhibir la actividad de SHP2
JO3517B1 (ar) 2014-01-17 2020-07-05 Novartis Ag ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2
US10858453B2 (en) 2015-04-01 2020-12-08 International Dioxcide, Inc. Stabilized composition for combined odor control and enhanced dewatering
JP6718889B2 (ja) 2015-06-19 2020-07-08 ノバルティス アーゲー Ｓｈｐ２の活性を阻害するための化合物および組成物
JP6878316B2 (ja) 2015-06-19 2021-05-26 ノバルティス アーゲー Ｓｈｐ２の活性を阻害するための化合物および組成物
WO2016203404A1 (en) 2015-06-19 2016-12-22 Novartis Ag Compounds and compositions for inhibiting the activity of shp2
CN108738310A (zh) 2015-09-30 2018-11-02 萨勒普塔医疗公司 用于治疗肌营养不良的方法
NZ747685A (en) 2016-04-29 2023-05-26 Sarepta Therapeutics Inc Oligonucleotide analogues targeting human lmna
CA3023216A1 (en) 2016-06-14 2017-12-21 Novartis Ag Compounds and compositions for inhibiting the activity of shp2
US20190262375A1 (en) 2016-06-30 2019-08-29 Sarepta Therapeutics, Inc. Exon skipping oligomers for muscular dystrophy
KR20240006057A (ko) 2016-12-19 2024-01-12 사렙타 쎄러퓨틱스 인코퍼레이티드 근육 이상증에 대한 엑손 스킵핑 올리고머 결합체
EP3554553B1 (en) 2016-12-19 2022-07-20 Sarepta Therapeutics, Inc. Exon skipping oligomer conjugates for muscular dystrophy
ES2980686T3 (es) 2016-12-19 2024-10-02 Sarepta Therapeutics Inc Conjugados de oligómero de omisión de exones para distrofia muscular
AU2018256435A1 (en) 2017-04-20 2019-11-07 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
EA201991450A1 (ru) 2017-09-22 2019-12-30 Сарепта Терапьютикс, Инк. Конъюгаты олигомеров для пропуска экзона при мышечной дистрофии
JP2020536057A (ja) 2017-09-28 2020-12-10 サレプタ セラピューティクス， インコーポレイテッド 筋ジストロフィーを処置するための併用療法
US20200248178A1 (en) 2017-09-28 2020-08-06 Sarepta Therapeutics, Inc. Combination therapies for treating muscular dystrophy
JP2020536058A (ja) 2017-09-28 2020-12-10 サレプタ セラピューティクス， インコーポレイテッド 筋ジストロフィーを処置するための併用療法
US10765760B2 (en) 2018-05-29 2020-09-08 Sarepta Therapeutics, Inc. Exon skipping oligomer conjugates for muscular dystrophy
EP4219717A3 (en) 2018-06-13 2023-12-20 Sarepta Therapeutics, Inc. Exon skipping oligomers for muscular dystrophy
CN108435148A (zh) * 2018-06-21 2018-08-24 黄益良 一种环糊精改性聚丙烯酰胺污水处理剂及其制备方法
TW202020153A (zh) 2018-07-27 2020-06-01 美商薩羅塔治療公司 用於肌肉萎縮症之外顯子跳躍寡聚物
CN113412330A (zh) 2018-12-13 2021-09-17 萨勒普塔医疗公司 用于肌营养不良的外显子跳跃寡聚物缀合物
US11279774B2 (en) 2019-01-03 2022-03-22 Underdog Pharmaceuticals, Inc. Cyclodextrin dimers, compositions thereof, and uses thereof
CN109663578B (zh) * 2019-02-22 2022-02-25 安徽大学 一种对刚果红超高吸附能力的混合卤化物(MV)[BiI3Cl2]的制备方法及其产品
CN109806849A (zh) * 2019-03-25 2019-05-28 东华大学 一种环糊精纳米空心小球及其制备方法
SG11202108757XA (en) 2019-03-28 2021-10-28 Sarepta Therapeutics Inc Methods for treating muscular dystrophy with casimersen
WO2020214763A1 (en) 2019-04-18 2020-10-22 Sarepta Therapeutics, Inc. Compositions for treating muscular dystrophy
JP2022536495A (ja) 2019-06-19 2022-08-17 サレプタ セラピューティクス， インコーポレイテッド 筋ジストロフィーを治療する方法
WO2021101606A1 (en) * 2019-11-18 2021-05-27 Pmidg, Llc Compositions for sunscreen compounds and methods thereof
CN113019344A (zh) * 2021-03-16 2021-06-25 大连理工大学 一种具有选择性吸附的球形零价铁-环糊精复合材料的制备方法及应用
CN113372674B (zh) * 2021-08-13 2021-10-19 山东三义集团股份有限公司 一种氯化聚乙烯用高速挤出加工改性助剂的制备方法
IL315280A (en) 2022-03-17 2024-10-01 Sarepta Therapeutics Inc Morpholino phosphorodiamidate oligomer conjugates
WO2024073570A1 (en) 2022-09-28 2024-04-04 Altos Labs, Inc. Expression of regeneration factors in aged/senescent cells
WO2024145608A2 (en) 2022-12-30 2024-07-04 Cornell University Acid cyclodextrins for the treatment of lipofuscin buildups and ocular diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2801184A (en) * 1952-01-18 1957-07-30 Miyamoto Katsuhei Colloidal suspension of amylose and alpha-amylodextrin
NL98574C (no) * 1958-01-29
US2977356A (en) * 1958-05-27 1961-03-28 Anheuser Busch Process for preparing cross-linked starch ethers in granule form
US2973243A (en) * 1958-08-26 1961-02-28 Kudera Dieter Process for producing threads, foils, tubes and the like from amylose and/or starch carbohydrates containing amylose
NL252506A (no) * 1959-06-12
US2989521A (en) * 1959-06-30 1961-06-20 Frederic R Senti Method of cross-linking and oxidizing starch
US3282870A (en) * 1963-11-29 1966-11-01 Dow Chemical Co Starch and polycarboxamide reaction products

Also Published As

Publication number Publication date
BE662174A (no) 1965-10-07
SE333240B (sv) 1971-03-08
ES312034A1 (es) 1966-02-01
DE1493047A1 (de) 1969-01-02
NO126377B (no) 1973-01-29
CH445129A (fr) 1967-10-15
DK132259B (da) 1975-11-17
US3420788A (en) 1969-01-07
SE365234B (no) 1974-03-18
GB1091637A (en) 1967-11-22
IT961352B (it) 1973-12-10
DK132259C (da) 1976-05-03
DE1493047B2 (de) 1973-01-11
NO127814B (no) 1973-08-20

Similar Documents

Publication Publication Date Title
GB1091637A (en) Inclusion resins
Wood et al. The effect of precipitation on the molecular weight distribution of cellulose tricarbanilate
Lee et al. Synthesis of a vinyl monomer containing β‐cyclodextrin and grafting onto cotton fiber
JPH0151822B2 (no)
CN105107485A (zh) 一种固化单宁吸附树脂的制备方法
CN109333719B (zh) 一种糠醇树脂木材改性剂及其制备方法与应用
SE7610611L (sv) Forfarande for framstellning av svellbara cellulosaetrar
Shimizu et al. Ethylenediamine tetraacetic acid modification of crosslinked chitosan designed for a novel metal‐ion adsorbent
ES333177A1 (es) Procedimiento para el tratamiento posterior de moldes para impresion plana, revelados con emulsion de barniz.
Kurita et al. ((Diethylamino) ethyl) chitins: preparation and properties of novel aminated chitin derivatives
GB1000082A (en) Graft polymers and methods of preparing them
Dee et al. N-Methylimidazole as a catalyst for acetylation of hydroxyl terminated polymers
EP1064128A1 (en) Process for producing a modified lignocellulosic material
GB918050A (en) Improvements in and relating to anchoring surface coatings to cellulosic surfaces
Achwal et al. Viscosity measurements on chemically modified celluloses
GB1002269A (en) Process for the manufacture of methylal
Clave et al. Crude and modified corncobs as complexing agents for water decontamination
FR2219192A1 (en) Thermosetting powdered coating compsns. - contg. polymer having reactive pendant hydroxyl gps., melamine-formaldehyde resin, and an acid-oxiran reaction prod.
Lederer et al. Adsorption chromatography on cellulose XIV. Some results using aqueous solutions of soluble cyclodextrin polymers as eluents
GB1505412A (en) Phenolic resins
JPS5763302A (en) Spherical particles of crosslinked porous amylose and its production
GB992201A (en) Method for the extraction of sulphated polysaccharides
ES313807A1 (es) Un procedimiento para preparar resinas termoplasticas de polihidroxipolieter de alto peso molecular.
GB1160306A (en) Process for Separating and Purifying Polymers of Epoxides from their Solutions in Hydrocarbons
US2986558A (en) Process for stabilizing solutions of cellulose derivatives